KR20120137407A - 유전자 시그너쳐 및 전기 전도 고주파 전류의 피부에의 투입과 관련된 유전자 칩과 그에 관련된 방법 및 처리 - Google Patents

유전자 시그너쳐 및 전기 전도 고주파 전류의 피부에의 투입과 관련된 유전자 칩과 그에 관련된 방법 및 처리 Download PDF

Info

Publication number
KR20120137407A
KR20120137407A KR1020127026405A KR20127026405A KR20120137407A KR 20120137407 A KR20120137407 A KR 20120137407A KR 1020127026405 A KR1020127026405 A KR 1020127026405A KR 20127026405 A KR20127026405 A KR 20127026405A KR 20120137407 A KR20120137407 A KR 20120137407A
Authority
KR
South Korea
Prior art keywords
skin
gene
treatment
genes
frequency current
Prior art date
Application number
KR1020127026405A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 존 와이즈거버
니키 엘리자베스 애넌지아타
티아 제닌 마우러
Original Assignee
더 프록터 앤드 갬블 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 프록터 앤드 갬블 캄파니 filed Critical 더 프록터 앤드 갬블 캄파니
Publication of KR20120137407A publication Critical patent/KR20120137407A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
KR1020127026405A 2010-04-19 2011-04-19 유전자 시그너쳐 및 전기 전도 고주파 전류의 피부에의 투입과 관련된 유전자 칩과 그에 관련된 방법 및 처리 KR20120137407A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32563310P 2010-04-19 2010-04-19
US61/325,633 2010-04-19
PCT/US2011/033033 WO2011133538A1 (en) 2010-04-19 2011-04-19 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto

Publications (1)

Publication Number Publication Date
KR20120137407A true KR20120137407A (ko) 2012-12-20

Family

ID=44343224

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127026405A KR20120137407A (ko) 2010-04-19 2011-04-19 유전자 시그너쳐 및 전기 전도 고주파 전류의 피부에의 투입과 관련된 유전자 칩과 그에 관련된 방법 및 처리

Country Status (8)

Country Link
EP (1) EP2561092A1 (pt)
JP (1) JP2013527756A (pt)
KR (1) KR20120137407A (pt)
CN (1) CN102869789B (pt)
BR (1) BR112012026870A2 (pt)
CA (1) CA2795671A1 (pt)
MX (1) MX2012012235A (pt)
WO (1) WO2011133538A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
EP2691539B1 (en) 2011-03-31 2018-04-25 The Procter and Gamble Company Methods for identifying and evaluating skin-active agents effective for treating dandruff
US10418127B2 (en) * 2012-03-30 2019-09-17 The Procter & Gamble Company Method of formulating a skin-lightening composition
EP2859486A2 (en) 2012-06-06 2015-04-15 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
EP2885423B1 (en) 2012-08-15 2017-09-27 The Procter and Gamble Company Systems for identifying and evaluating skin-active agents effective for treating an array of skin disorders
WO2016077327A1 (en) 2014-11-10 2016-05-19 The Procter & Gamble Company Personal care compositions with two benefit phases
CN107106429B (zh) 2014-11-10 2021-06-29 宝洁公司 具有两种有益相的个人护理组合物
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company CLEANER FOR AEROSOL MOUSSE FOAM
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
CN113015904A (zh) 2018-11-29 2021-06-22 宝洁公司 用于筛选个人护理产品的方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0430881A3 (en) 1989-11-29 1991-10-23 Ciba-Geigy Ag Photochromic compounds, process for their preparation and their use
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5366443A (en) 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
EP0636186B1 (en) 1992-04-03 1998-11-25 The Perkin-Elmer Corporation Probe composition and method
US5503980A (en) 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US6430446B1 (en) 1995-05-05 2002-08-06 Thermage, Inc. Apparatus for tissue remodeling
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
US6228078B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
ATE298536T1 (de) 1999-03-09 2005-07-15 Thermage Inc Vorichtung zur behandlung von gewebe
US20020087155A1 (en) * 1999-08-30 2002-07-04 Underwood Ronald A. Systems and methods for intradermal collagen stimulation
US6702808B1 (en) 2000-09-28 2004-03-09 Syneron Medical Ltd. Device and method for treating skin
WO2002032332A1 (en) * 2000-10-18 2002-04-25 Mattoli Engineering Ltd. Method and apparatus for plasma skin resurfacing
US6889090B2 (en) 2001-11-20 2005-05-03 Syneron Medical Ltd. System and method for skin treatment using electrical current
US6662054B2 (en) 2002-03-26 2003-12-09 Syneron Medical Ltd. Method and system for treating skin
EP1558339A1 (en) 2002-10-07 2005-08-03 Palomar Medical Technologies, Inc. Apparatus for performing photobiostimulation
US7643883B2 (en) * 2005-01-28 2010-01-05 Syneron Medical Ltd. Device and method for treating skin
SI22738A (sl) * 2008-04-11 2009-10-31 Iskra Medical, D.O.O. Naprava za radiofrekvenčno krožno globinsko terapijo

Also Published As

Publication number Publication date
WO2011133538A1 (en) 2011-10-27
BR112012026870A2 (pt) 2017-01-10
MX2012012235A (es) 2012-11-23
JP2013527756A (ja) 2013-07-04
CN102869789B (zh) 2015-09-30
CN102869789A (zh) 2013-01-09
EP2561092A1 (en) 2013-02-27
CA2795671A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
KR20120137407A (ko) 유전자 시그너쳐 및 전기 전도 고주파 전류의 피부에의 투입과 관련된 유전자 칩과 그에 관련된 방법 및 처리
AU2020270508B2 (en) C/EBP alpha short activating RNA compositions and methods of use
AU2019201577B2 (en) Cancer diagnostics using biomarkers
CN107077536B (zh) 使用靶基因表达的数学建模评价TGF-β细胞信号传导途径的活性
KR101234281B1 (ko) 염색체 안정화에 관한 유전자를 표적으로 하는 암세포 특이적 아포토시스 유도제
AU2023251441A1 (en) RNA containing composition for treatment of tumor diseases
RU2721130C2 (ru) Оценка активности путей клеточной сигнализации с помощью линейной комбинации(ий) экспрессий генов-мишеней
RU2719194C2 (ru) Оценка активности клеточных сигнальных путей с применением вероятностного моделирования экспрессии целевых генов
US6262333B1 (en) Human genes and gene expression products
AU2018210695A1 (en) Molecular subtyping, prognosis, and treatment of bladder cancer
KR20120082906A (ko) 자가포식현상-향상 유전자 생성물의 조절을 통한 자가포식현상의 조절 방법
KR20190100967A (ko) 트리플 가이드 서열을 지닌 crispr/cas9를 사용한 엑손 스키핑 변형을 위한 최적화된 전략
KR101421326B1 (ko) 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
CN101258249A (zh) 检测黑素瘤的方法和试剂
WO1995014772A1 (fr) Signature genique
KR20140140069A (ko) 전반적 발달장애의 진단 및 치료용 조성물 및 그 진단 및 치료 방법
MXPA05005653A (es) Determinacion y seleccion terapeutica de genes de insuficiencia cardiaca.
KR20040065524A (ko) 백혈병을 검사 및 치료하는 방법
KR20220054401A (ko) 감염의 숙주 rna 바이오마커의 신속한 조기-검출 및 인간의 covid-19 코로나바이러스 감염의 조기 식별을 위한 시스템, 방법 및 조성물
KR102195319B1 (ko) 상처치료제 스크리닝용 조성물 및 이를 이용한 상처 치료제 스크리닝 방법
KR20070099564A (ko) 급성 골수성 백혈병 환자를 평가하는 방법
KR101490573B1 (ko) 포유류 피부의 상태를 조절하기 위한 조합된 에너지 및 국소 조성물 적용
KR20140113021A (ko) 약물 중독 및 의존성 확인용 바이오마커
KR20100037637A (ko) Ｅｇｆｒ 억제제 치료에 대한 예측 마커
US20220265798A1 (en) Cancer vaccine compositions and methods for using same to prevent and/or treat cancer

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
E902 Notification of reason for refusal
E601 Decision to refuse application